Wazana A
McGill University, Montreal, Quebec, Canada.
JAMA. 2000 Jan 19;283(3):373-80. doi: 10.1001/jama.283.3.373.
Controversy exists over the fact that physicians have regular contact with the pharmaceutical industry and its sales representatives, who spend a large sum of money each year promoting to them by way of gifts, free meals, travel subsidies, sponsored teachings, and symposia.
To identify the extent of and attitudes toward the relationship between physicians and the pharmaceutical industry and its representatives and its impact on the knowledge, attitudes, and behavior of physicians.
A MEDLINE search was conducted for English-language articles published from 1994 to present, with review of reference lists from retrieved articles; in addition, an Internet database was searched and 5 key informants were interviewed.
A total of 538 studies that provided data on any of the study questions were targeted for retrieval, 29 of which were included in the analysis.
Data were extracted by 1 author. Articles using an analytic design were considered to be of higher methodological quality.
Physician interactions with pharmaceutical representatives were generally endorsed, began in medical school, and continued at a rate of about 4 times per month. Meetings with pharmaceutical representatives were associated with requests by physicians for adding the drugs to the hospital formulary and changes in prescribing practice. Drug company-sponsored continuing medical education (CME) preferentially highlighted the sponsor's drug(s) compared with other CME programs. Attending sponsored CME events and accepting funding for travel or lodging for educational symposia were associated with increased prescription rates of the sponsor's medication. Attending presentations given by pharmaceutical representative speakers was also associated with nonrational prescribing.
The present extent of physician-industry interactions appears to affect prescribing and professional behavior and should be further addressed at the level of policy and education.
医生与制药行业及其销售代表保持定期接触,而这些销售代表每年花费大量资金通过礼品、免费餐食、差旅补贴、赞助教学和研讨会等方式向医生进行推广,这一现象存在争议。
确定医生与制药行业及其代表之间关系的程度和态度,以及这种关系对医生的知识、态度和行为的影响。
对1994年至今发表的英文文章进行了MEDLINE检索,并查阅了检索文章的参考文献列表;此外,搜索了一个互联网数据库,并采访了5名关键信息提供者。
总共检索了538项提供了任何研究问题数据的研究,其中29项纳入分析。
由1名作者提取数据。采用分析设计的文章被认为具有较高的方法学质量。
医生与制药代表的互动普遍得到认可,始于医学院,并以每月约4次的频率持续。与制药代表的会面与医生要求将药物纳入医院处方集以及处方实践的改变有关。与其他继续医学教育项目相比,制药公司赞助的继续医学教育(CME)优先突出赞助商的药物。参加赞助的CME活动以及接受教育研讨会的差旅或住宿资金与赞助商药物的处方率增加有关。参加制药代表演讲也与不合理处方有关。
目前医生与行业的互动程度似乎影响处方和专业行为,应在政策和教育层面进一步加以解决。